Originally published by our sister publication Pharmacy Practice News
Clinical Assistant Professor, Drug Information Specialist
University of Illinois Chicago Retzky College of Pharmacy
University of Illinois Chicago Retzky College of Pharmacy
Biologics are mainstays of treatment for many chronic inflammatory conditions.1 Unfortunately, these drugs often come with high price tags due to the significant costs associated with their development and manufacturing.2 In recent years, several biosimilar products have been developed,